Nitric oxide repression of Nanog promotes mouse embryonic stem cell differentiation

Cell Death and Differentiation

Volumn 17, Issue 6, 2010, Pages 1025-1033

  Mora Castilla, S ^a   Tejedo, J R ^a   Hmadcha, A ^a   Cahuana, G M ^a   Martin F ^a   Soria, B ^a   Bedoya, F J ^a  

^a CABIMER Andalusian Center for Molecular Biology and Regenerative Medicine CSIC University of Seville UPO   (Spain)

Author keywords

Differentiation; Embryonic stem cell; Nanog; Nitric oxide; Oct4 repression; Self renewal

Indexed keywords

DIETHYLENETRIAMINE; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 3BETA; HISTONE H3; LYSINE; NITRIC OXIDE; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN P53; REPRESSOR PROTEIN; SERINE; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX17; VALPROIC ACID;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EMBRYO CULTURE; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; ENDODERM; ENZYME ACTIVATION; ENZYME REPRESSION; EPITHELIUM CELL; GENE CONTROL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MODIFICATION;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE; DOWN-REGULATION; EMBRYONIC STEM CELLS; ENDODERM; HISTONES; HOMEODOMAIN PROTEINS; MICE; NITRIC OXIDE; NITRIC OXIDE DONORS; OCTAMER TRANSCRIPTION FACTOR-3; PHENOTYPE; PROMOTER REGIONS, GENETIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77952238024     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2009.204     Document Type: Article

References (40)

1. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000; 24: 372-376. (Pubitemid 30187435)
2. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003; 113: 631-642. (Pubitemid 36694188)
3. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003; 113: 643-655. (Pubitemid 36694189)
4. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005; 122: 947-956. (Pubitemid 41345211)
5. Pan G, Thomson JA. Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res 2007; 17: 42-49. (Pubitemid 46096423)
6. Hamazaki T, Oka M, Yamanaka S, Terada N. Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation. J Cell Sci 2004; 117 (Part 23): 5681-5686. (Pubitemid 40012213)
7. Lin T, Chao C, Saito S, Mazur SJ, Murphy ME, Appella E et al. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 2005; 7: 165-171. (Pubitemid 40268131)
8. Han MK, Song EK, Guo Y, Ou X, Mantel C, Broxmeyer HE. SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell 2008; 2: 241-251. (Pubitemid 351298591)
9. Gu W, Roeder RG. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 1997; 90: 595-606. (Pubitemid 27357952)
10. Lee JH, Hart SR, Skalnik DG. Histone deacetylase activity is required for embryonic stem cell differentiation. Genesis 2004; 38: 32-38. (Pubitemid 38197607)
11. Loh YH, Zhang W, Chen X, George J, Ng HH. Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes Dev 2007; 21: 2545-2557. (Pubitemid 47607666)
12. Kuo RC, Baxter GT, Thompson SH, Stricker SA, Patton C, Bonaventura J et al. NO is necessary and sufficient for egg activation at fertilization. Nature 2000; 406: 633-636. (Pubitemid 30641050)
13. Sengoku K, Takuma N, Horikawa M, Tsuchiya K, Komori H, Sharifa D et al. Requirement of nitric oxide for murine oocyte maturation, embryo development, and trophoblast outgrowth in vitro. Mol Reprod Dev 2001; 58: 262-268. (Pubitemid 32121444)
14. Gouge RC, Marshburn P, Gordon BE, Nunley W, Huet-Hudson YM. Nitric oxide as a regulator of embryonic development. Biol Reprod 1998; 58: 875-879. (Pubitemid 28144973)
15. Kanno S, Kim PK, Sallam K, Lei J, Billiar TR, Shears II LL. Nitric oxide facilitates cardiomyogenesis in mouse embryonic stem cells. Proc Natl Acad Sci USA 2004; 101: 12277-12281. (Pubitemid 39145434)
16. Paquin J, Danalache BA, Jankowski M, McCann SM, Gutkowska J. Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes. Proc Natl Acad Sci USA 2002; 99: 9550-9555. (Pubitemid 34764650)
17. Danalache BA, Paquin J, Donghao W, Grygorczyk R, Moore JC, Mummery CL et al. Nitric oxide signaling in oxytocin-mediated cardiomyogenesis. Stem cells (Dayton, OH) 2007; 25: 679-688. (Pubitemid 46354227)
18. Gassanov N, Jankowski M, Danalache B, Wang D, Grygorczyk R, Hoppe UC et al. Arginine vasopressin-mediated cardiac differentiation: insights into the role of its receptors and nitric oxide signaling. J Biol Chem 2007; 282: 11255-11265. (Pubitemid 47100804)
19. Bloch W, Fleischmann BK, Lorke DE, Andressen C, Hops B, Hescheler J et al. Nitric oxide synthase expression and role during cardiomyogenesis. Cardiovasc Res 1999; 43: 675-684. (Pubitemid 29369266)
20. Mujoo K, Sharin VG, Bryan NS, Krumenacker JS, Sloan C, Parveen S et al. Role of nitric oxide signaling components in differentiation of embryonic stem cells into myocardial cells. Proc Natl Acad Sci USA 2008; 105: 18924-18929.
21. Wang X, Michael D, de Murcia G, Oren M. p53 Activation by nitric oxide involves down-regulation of Mdm2. J Biol Chem 2002; 277: 15697-15702. (Pubitemid 34967843)
22. Yung HW, Bal-Price AK, Brown GC, Tolkovsky AM. Nitric oxide-induced cell death of cerebrocortical murine astrocytes is mediated through p53-and Bax-dependent pathways. J Neurochem 2004; 89: 812-821.
23. McLaughlin LM, Demple B. Nitric oxide-induced apoptosis in lymphoblastoid and fibroblast cells dependent on the phosphorylation and activation of p53. Cancer Res 2005; 65: 6097-6104. (Pubitemid 40994394)
24. Qin H, Yu T, Qing T, Liu Y, Zhao Y, Cai J et al. Regulation of apoptosis and differentiation by p53 in human embryonic stem cells. J Biol Chem 2007; 282: 5842-5852. (Pubitemid 47093795)
25. Hamazaki T, Kehoe SM, Nakano T, Terada N. The Grb2/Mek pathway represses Nanog in murine embryonic stem cells. Mol Cell Biol 2006; 26: 7539-7549. (Pubitemid 44547704)
26. Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, Chen X et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 2006; 38: 431-440.
27. Guo Y, Costa R, Ramsey H, Starnes T, Vance G, Robertson K et al. The embryonic stem cell transcription factors Oct-4 and FoxD3 interact to regulate endodermal-specific promoter expression. Proc Natl Acad Sci USA 2002; 99: 3663-3667. (Pubitemid 34252163)
28. Maimets T, Neganova I, Armstrong L, Lako M. Activation of p53 by nutlin leads to rapid differentiation of human embryonic stem cells. Oncogene 2008; 27: 5277-5287.
29. Kroon E, Martinson LA, Kadoya K, Bang AG, Kelly OG, Eliazer S et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 2008; 26: 443-452.
30. D'Amour KA, Agulnick AD, Eliazer S, Kelly OG, Kroon E, Baetge EE. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 2005; 23: 1534-1541.
31. D'Amour KA, Bang AG, Eliazer S, Kelly OG, Agulnick AD, Smart NG et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 2006; 24: 1392-1401.
32. Lavin MF, Gueven N. The complexity of p53 stabilization and activation. Cell Death Differ 2006; 13: 941-950.
33. Blaydes JP, Luciani MG, Pospisilova S, Ball HM, Vojtesek B, Hupp TR. Stoichiometric phosphorylation of human p53 at Ser315 stimulates p53-dependent transcription. J Biol Chem 2001; 276: 4699-4708.
34. Nemajerova A, Erster S, Moll UM. The post-translational phosphorylation and acetylation modification profile is not the determining factor in targeting endogenous stress-induced p53 to mitochondria. Cell Death Differ 2005; 12: 197-200.
35. Francis NJ, Kingston RE. Mechanisms of transcriptional memory. Nat Rev 2001; 2: 409-421.
36. Haumaitre C, Lenoir O, Scharfmann R. Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors. Mol Cell Biol 2008; 28: 6373-6383.
37. Vaca P, Berna G, Araujo R, Carneiro EM, Bedoya FJ, Soria B et al. Nicotinamide induces differentiation of embryonic stem cells into insulin-secreting cells. Exp Cell Res 2008; 314: 969-974.
38. Goicoa S, Alvarez S, Ricordi C, Inverardi L, Dominguez-Bendala J. Sodium butyrate activates genes of early pancreatic development in embryonic stem cells. Cloning Stem Cells 2006; 8: 140-149.
39. Hovatta O, Mikkola M, Gertow K, Stromberg AM, Inzunza J, Hreinsson J et al. A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Hum Reprod (Oxford, England) 2003; 18: 1404-1409.
40. Ensenat-Waser R, Santana A, Vicente-Salar N, Cigudosa JC, Roche E, Soria B et al. Isolation and characterization of residual undifferentiated mouse embryonic stem cells from embryoid body cultures by fluorescence tracking. In Vitro Cell Dev Biol Anim 2006; 42: 115-123.